Related Experiment Video
Updated: Nov 16, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Structural basis of the p53 DNA binding domain and PUMA complex
Chang Woo Han1, Han Na Lee1, Mi Suk Jeong2
1Department of Molecular Biology, College of Natural Sciences, Pusan National University, 2Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan, 46241, Republic of Korea.
Abstract:
PUMA (p53-upregulated modulator of apoptosis) is localized in mitochondria and a direct target in p53-mediated apoptosis. p53 elicits mitochondrial apoptosis via transcription-dependent and independent mechanisms. p53 is known to induce apoptosis via the transcriptional induction of PUMA, which encodes proapoptotic BH3-only members of the Bcl-2 protein family. However, the transcription-independent mechanisms of human PUMA remain poorly defined. For example, it is not known whether PUMA interacts directly with the DNA binding domain (DBD: residues 92-293) of p53 in vitro. Here, the structure of the complex between the DBD of p53 and PUMA peptide was elucidated by X-ray crystallography. Isothermal titration calorimetry showed that PUMA peptide binds strongly with p53 DBD, and the crystal structure of p53-PUMA peptide complex revealed it contains four molecules of p53 DBD and one PUMA peptide per asymmetric unit in space group P1. PUMA peptide bound to the N-terminal residues of p53 DBD. A cell proliferation assay demonstrated PUMA peptide inhibited the growth of a lung cancer cell line. These results contribute to understanding of the mechanism responsible for p53-mediated apoptosis.
Insights
The p53-upregulated modulator of apoptosis (PUMA) peptide directly binds the p53 DNA binding domain. This interaction inhibits lung cancer cell growth, shedding light on p53-mediated apoptosis mechanisms.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Research
Background:
- PUMA is a key mitochondrial protein in p53-mediated apoptosis.
- p53 induces apoptosis through both transcription-dependent and independent pathways.
- The transcription-independent interaction between p53 and PUMA is not well understood.
Purpose of the Study:
- To investigate the direct interaction between the p53 DNA binding domain (DBD) and PUMA.
- To elucidate the structural basis of the p53 DBD-PUMA interaction.
- To assess the functional consequence of PUMA binding to p53 DBD in cancer cells.
Main Methods:
- X-ray crystallography to determine the complex structure.
- Isothermal titration calorimetry (ITC) for binding affinity.
- Cell proliferation assays to evaluate functional impact.
Main Results:
- PUMA peptide binds strongly to the p53 DBD in vitro.
- The crystal structure revealed PUMA peptide binding to the N-terminal residues of p53 DBD.
- PUMA peptide demonstrated inhibition of lung cancer cell line growth.
Conclusions:
- PUMA directly interacts with the p53 DBD, elucidating a transcription-independent apoptotic mechanism.
- Structural data provides insights into the p53-PUMA complex formation.
- PUMA peptide exhibits anti-proliferative effects on lung cancer cells, suggesting therapeutic potential.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
DNA Damage can Stall the Cell Cycle
Single-Strand DNA Binding Proteins
Protein-protein Interfaces

